Indivior (INDV)

Sector:

Pharma and Biotech

Index:

FTSE 250

983.00p
   
  • Change Today:
    -17.00p
  • 52 Week High: 1,383.00p
  • 52 Week Low: 576.50p
  • Currency: UK Pounds
  • Shares Issued: 124.77m
  • Volume: 56,200
  • Market Cap: £1,226.48m
  • RiskGrade: 314

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

Key Personnel

CEO: Mark Crossley
Chairman: David E. Wheadon
Independent Non-Executive Director: Joe Ciaffoni
Independent Non-Executive Director: Barbara Ryan
Independent Non-Executive Director: Daniel A. Ninivaggi
Independent Non-Executive Director: Keith Humphreys
Independent Non-Executive Director: Jo Le Couilliard
Independent Non-Executive Director: Mark Stejbach
Independent Non-Executive Director: Peter Bains
Senior Independent Director: Juliet Thompson
Non-Executive Dir:

Contact Details

Address: 234 Bath Road, Slough, Berkshire, United Kingdom, SL1 4EE
Website: http://www.Indivior.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 250, FTSE 350, FTSE All-Share
Overseas Listings: BATSLON:INDVL
ISIN: GB00BN4HT335

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Indivior Market Data

Currency UK Pounds
Share Price 983.00p
Change Today -17.00p
% Change -1.70 %
52 Week High 1,383.00p
52 Week Low 576.50p
Volume 56,200
Shares Issued 124.77m
Market Cap £1,226.48m
RiskGrade 314

Indivior Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.73% below the market average53.73% below the market average53.73% below the market average53.73% below the market average53.73% below the market average
30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average
Price Trend
66.92% above the market average66.92% above the market average66.92% above the market average66.92% above the market average66.92% above the market average
13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average
Income Not Available
Growth
50.82% above the market average50.82% above the market average50.82% above the market average50.82% above the market average50.82% above the market average
10.34% above the sector average10.34% above the sector average10.34% above the sector average10.34% above the sector average10.34% above the sector average

What The Brokers Say

Strong Buy 2
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Indivior Dividends

No dividends found

Trades for 05-Jun-2025

Time Volume / Share Price
11:51 38 @ 983.00p
11:45 2 @ 977.50p
11:45 16 @ 982.00p
11:45 30 @ 982.00p
11:42 350 @ 982.60p

Indivior Key Personnel

CEO Mark Crossley
Chair David E. Wheadon

Top of Page